However, given that CD8 was included as a dichotomous variable (in absence/presence) in a study by Stanton et al. and that hormone receptor positive HER-2-positive breast cancer was included within HER-2-positive breast cancer, it seemed difficult to compare the results directly. This evidence concerns the gene ERBB2 and breast carcinoma.